Regen BioPharma Inc (RGBP)

[SanDiegoAlan]

On November 28, 2018 the Company issued 10,000,000 Common Shares (“Shares”) in satisfaction of $2,896 of convertible indebtedness, $500 in fees and $5,903 of accrued interest due on convertible indebtedness.

That works out to be 0.0009299 per share, they are selling to retail investors that think this is a good investment for .002 to .0029 per share.

Must be nice to be a convertible note holder, Easy money.

I'm just pointing out that due diligence requires a little investigative reading and arithmetic. Not just fawning over rah rah PRs.